MARKET

PTCT

PTCT

Ptc Therapeutics
NASDAQ
65.03
-0.41
-0.63%
After Hours: 65.97 +0.94 +1.45% 16:55 11/09 EST
OPEN
66.91
PREV CLOSE
65.44
HIGH
66.91
LOW
64.12
VOLUME
843.28K
TURNOVER
--
52 WEEK HIGH
90.87
52 WEEK LOW
58.80
MARKET CAP
5.43B
P/E (TTM)
-47.2190
1D
5D
1M
3M
1Y
5Y
1D
Why Everyone Is Watching PTC Therapeutics (PTCT) Today
Simply Wall St · 22h ago
Weekly Report: what happened at PTCT last week (1102-1106)?
Weekly Report · 1d ago
PTC Therapeutics (PTCT) Gets a Buy from J.P. Morgan
TipRanks · 3d ago
PTC Therapeutics (PTCT) Stock Could Be Near Fair Value Today
Simply Wall St · 5d ago
Former Biopharma Execs Lists Florida Compound With Rooftop Pool for $64 Million
The Wall Street Journal · 6d ago
PTC Therapeutics, Inc. Announces $500.0 Million Share Repurchase Program
NASDAQ · 6d ago
Healthcare Stocks Move Higher: SIBN Rallies 18%, NBIX Gains 16%, RMTI Climbs 16%, PTCT Up 13%
NASDAQ · 6d ago
Why PTC Therapeutics Bears Were Right Before The Drop
Simply Wall St · 6d ago
More
About PTCT
PTC Therapeutics, Inc. is a global biopharmaceutical company. It is focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. It has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD), a rare life-threatening disorder. Its Upstaza, a gene therapy for the treatment of Aromatic L-Amino Decarboxylase (AADC) deficiency, a rare central nervous system (CNS) disorder. Its ST-920, or isaralgagene civaparvovec, is a one-time administered AAV gene therapy product candidate for the treatment of Fabry disease.

Webull offers PTC Therapeutics, Inc. stock information, including NASDAQ: PTCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTCT stock methods without spending real money on the virtual paper trading platform.